Cost-effectiveness of real-world administration of tobacco pharmacotherapy in the United States Veterans Health Administration.
Paul G BarnettRosalinda V IgnacioHyungjin Myra KimMark C GeraciCarol A EssenmacherStephanie V HallScott E ShermanSonia A DuffyPublished in: Addiction (Abingdon, England) (2019)
Tobacco cessation pharmacotherapy provided by the US Veterans Health Administration in 2011/12 was cost-effective in this real-world setting, with an incremental cost-effectiveness ratio of $4705 per quit.